Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stroncek

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Current Opinion in Hematology|September 28, 2007
Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177David F Stroncek
Seminars in Hematology|January 3, 2007
Pulmonary transfusion reactionsDavid F Stroncek
Blood Research|April 17, 2013
Blood Research: hematology and beyondDavid F Stroncek
Transfusion|January 12, 2011
Is it time to reconsider neutrophil antibody testing of platelet donors?David F Stroncek, Mary Clay
Journal of Translational Medicine|October 13, 2006
Recent advances in the bcr-abl negative chronic myeloproliferative diseasesMichael Bennett, David F Stroncek
Lancet (London, England)|August 7, 2007
Platelet transfusionsDavid F Stroncek, Paolo Rebulla
Transfusion|January 4, 2024
Healthcare center-based cell therapy laboratories supporting off-site manufactured cell therapies: The experiences of a single academic cell therapy laboratoryAnh Dinh, David F Stroncek
ISBT Science Series|May 5, 2015
Protecting the Health and Safety of Cell and Tissue DonorsDavid F Stroncek, Lee England
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2026
Bringing in vivo CAR to the clinic: Promise, pitfalls, and questions to askAlexandra Dreyzin, David F Stroncek
Blood|November 5, 2016
Gene therapy simplifiedJiaqiang Ren, David F Stroncek
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Current Opinion in Hematology|September 28, 2007
Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177David F Stroncek
Seminars in Hematology|January 3, 2007
Pulmonary transfusion reactionsDavid F Stroncek
Blood Research|April 17, 2013
Blood Research: hematology and beyondDavid F Stroncek
Transfusion|January 12, 2011
Is it time to reconsider neutrophil antibody testing of platelet donors?David F Stroncek, Mary Clay
Journal of Translational Medicine|October 13, 2006
Recent advances in the bcr-abl negative chronic myeloproliferative diseasesMichael Bennett, David F Stroncek
Lancet (London, England)|August 7, 2007
Platelet transfusionsDavid F Stroncek, Paolo Rebulla
Transfusion|January 4, 2024
Healthcare center-based cell therapy laboratories supporting off-site manufactured cell therapies: The experiences of a single academic cell therapy laboratoryAnh Dinh, David F Stroncek
ISBT Science Series|May 5, 2015
Protecting the Health and Safety of Cell and Tissue DonorsDavid F Stroncek, Lee England
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2026
Bringing in vivo CAR to the clinic: Promise, pitfalls, and questions to askAlexandra Dreyzin, David F Stroncek
Blood|November 5, 2016
Gene therapy simplifiedJiaqiang Ren, David F Stroncek
Pageof 22